389 related articles for article (PubMed ID: 11964599)
21. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein.
Thompson SJ; Koszdin K; Bernards CM
Anesthesiology; 2000 May; 92(5):1392-9. PubMed ID: 10781286
[TBL] [Abstract][Full Text] [Related]
22. The effect of fentanyl, sufentanil, and alfentanil on cerebral arterioles in piglets.
Monitto CL; Kurth CD
Anesth Analg; 1993 May; 76(5):985-9. PubMed ID: 8484556
[TBL] [Abstract][Full Text] [Related]
23. Utility of P-glycoprotein and organic cation transporter 1 double-transfected LLC-PK1 cells for studying the interaction of YM155 monobromide, novel small-molecule survivin suppressant, with P-glycoprotein.
Iwai M; Minematsu T; Li Q; Iwatsubo T; Usui T
Drug Metab Dispos; 2011 Dec; 39(12):2314-20. PubMed ID: 21918035
[TBL] [Abstract][Full Text] [Related]
24. The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel.
Crowe A
Eur J Pharmacol; 2002 Apr; 440(1):7-16. PubMed ID: 11959083
[TBL] [Abstract][Full Text] [Related]
25. A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein.
Gibbs ME; Wilt LA; Ledwitch KV; Roberts AG
J Pharm Sci; 2018 Jul; 107(7):1937-1947. PubMed ID: 29499278
[TBL] [Abstract][Full Text] [Related]
26. Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein.
Dilger K; Schwab M; Fromm MF
Inflamm Bowel Dis; 2004 Sep; 10(5):578-83. PubMed ID: 15472518
[TBL] [Abstract][Full Text] [Related]
27. Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil.
Ummenhofer WC; Arends RH; Shen DD; Bernards CM
Anesthesiology; 2000 Mar; 92(3):739-53. PubMed ID: 10719953
[TBL] [Abstract][Full Text] [Related]
28. Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells.
Acharya P; O'Connor MP; Polli JW; Ayrton A; Ellens H; Bentz J
Drug Metab Dispos; 2008 Feb; 36(2):452-60. PubMed ID: 17967933
[TBL] [Abstract][Full Text] [Related]
29. Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.
Takara K; Sakaeda T; Kakumoto M; Tanigawara Y; Kobayashi H; Okumura K; Ohnishi N; Yokoyama T
Oncol Res; 2009; 17(11-12):527-33. PubMed ID: 19806783
[TBL] [Abstract][Full Text] [Related]
30. Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp.
Lumen AA; Li L; Li J; Ahmed Z; Meng Z; Owen A; Ellens H; Hidalgo IJ; Bentz J
PLoS One; 2013; 8(8):e69394. PubMed ID: 23976943
[TBL] [Abstract][Full Text] [Related]
31. Development of a gas chromatographic-mass spectrometric drug screening method for the N-dealkylated metabolites of fentanyl, sufentanil, and alfentanil.
Valaer AK; Huber T; Andurkar SV; Clark CR; DeRuiter J
J Chromatogr Sci; 1997 Oct; 35(10):461-6. PubMed ID: 9336954
[TBL] [Abstract][Full Text] [Related]
32. [Sufentanil. An alternative to fentanyl/alfentanil?].
Ellmauer S
Anaesthesist; 1994 Mar; 43(3):143-58. PubMed ID: 8179164
[TBL] [Abstract][Full Text] [Related]
33. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
[TBL] [Abstract][Full Text] [Related]
34. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
[TBL] [Abstract][Full Text] [Related]
35. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.
Tahara K; Kagawa Y; Takaai M; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2008; 23(5):340-6. PubMed ID: 18974611
[TBL] [Abstract][Full Text] [Related]
36. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
Scholz J; Steinfath M; Schulz M
Clin Pharmacokinet; 1996 Oct; 31(4):275-92. PubMed ID: 8896944
[TBL] [Abstract][Full Text] [Related]
37. P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells.
Letrent SP; Polli JW; Humphreys JE; Pollack GM; Brouwer KR; Brouwer KL
Biochem Pharmacol; 1999 Sep; 58(6):951-7. PubMed ID: 10509747
[TBL] [Abstract][Full Text] [Related]
38. Influence of high-dose opioid anesthesia on posterior tibial nerve somatosensory cortical evoked potentials: effects of fentanyl, sufentanil, and alfentanil.
Kalkman CJ; Leyssius AT; Bovill JG
J Cardiothorac Anesth; 1988 Dec; 2(6):758-64. PubMed ID: 17171885
[TBL] [Abstract][Full Text] [Related]
39. Effects of fentanyl, alfentanil, remifentanil and sufentanil on loss of consciousness and bispectral index during propofol induction of anaesthesia.
Lysakowski C; Dumont L; Pellegrini M; Clergue F; Tassonyi E
Br J Anaesth; 2001 Apr; 86(4):523-7. PubMed ID: 11573626
[TBL] [Abstract][Full Text] [Related]
40. Fitting the elementary rate constants of the P-gp transporter network in the hMDR1-MDCK confluent cell monolayer using a particle swarm algorithm.
Agnani D; Acharya P; Martinez E; Tran TT; Abraham F; Tobin F; Ellens H; Bentz J
PLoS One; 2011; 6(10):e25086. PubMed ID: 22028772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
